Versant Venture Capital VI, L.P. sold LENZ
September 18, 2025 · Form 4 insider transaction
Versant Venture Capital VI, L.P. sold 132 shares of LENZ Therapeutics, Inc. at $43.30 per share, a transaction worth $5.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
These shares are held by Versant Venture Capital VII, L.P. ("VVC VII"). Versant Ventures VII GP-GP, LLC ("VV VII GP") is the sole general partner of Versant Ventures VII GP, L.P. ("VV VII") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.